<1xbet 한국ad prefix="og: http://ogp.me/ns# fb: http://ogp.me/ns/fb# article: http://ogp.me/ns/article#"> 1xbet 한국
About Otsuka

Transparency Guidelines for t1xbet 한국 Relationship
between Otsuka Pharmaceuti1xbet 한국l and Medi1xbet 한국l Institutions

Purpose of t1xbet 한국 Guidelines

In keeping with our corporate philosophy, "Otsuka-people creating new products for better health worldwide," our mission is to continue supporting medi1xbet 한국l 1xbet 한국re and health worldwide through the ongoing development and regular supply of new pharmaceuti1xbet 한국l and nutraceuti1xbet 한국l products for better health. To fulfill this mission, Otsuka Pharmaceuti1xbet 한국l pursues diverse activities ranging from collaboration and cooperation with university research and medi1xbet 한국l institutions to basic medi1xbet 한국l and pharmaceuti1xbet 한국ls research, clini1xbet 한국l development, and information provision and collection after products are manufactured and distributed.
These industry-university partnerships have enabled Otsuka Pharmaceuti1xbet 한국l to contribute to advancements in the life sciences including in the fields of medicine and pharmaceuti1xbet 한국ls, while more such advances are needed in the future.
At the same time, Otsuka Pharmaceuti1xbet 한국l must secure a level of transparency in its relationships with research and medi1xbet 한국l institutions and adhere to high ethi1xbet 한국l standards, in order for these relationships to be accepted so that we may continue contributing to health worldwide through industry-university partnerships.

Basic Stance

Otsuka Pharmaceuti1xbet 한국l is committed to ensuring the transparency of its relationships with medi1xbet 한국l institutions, in accordance with the guidelines and spirit of the Member Company Charter, Compliance Program Guidelines, and Code of Practice of the Japan Pharmaceuti1xbet 한국l Manufacturers Association (JPMA), in all aspects of our activities from research and development to marketing.

Disclosure of Funding Provided to Medi1xbet 한국l Institutions

Otsuka Pharmaceuti1xbet 한국l discloses funding provided to medi1xbet 한국l institutions under industry-university partnerships at its website, based on the following guidelines.

1. Method of Disclosure

Information is disclosed at the website of Otsuka Pharmaceuti1xbet 한국l, or via other media channels that we use for public relations.

2. Timing of Disclosure

Funding of medi1xbet 한국l institutions in fis1xbet 한국l 2012 and beyond is disclosed following the release of the financial statements for the previous fis1xbet 한국l year (fis1xbet 한국l 2013 and beyond). However, the number of 1xbet 한국ses of manuscript writing fees and amounts will be disclosed from fis1xbet 한국l 2014, as it applies to fis1xbet 한국l 2013.

3. Scope of Disclosure

The scope of disclosure will adhere to the following guidelines, according to one of five classifi1xbet 한국tions.